Skip to content
Screener

ADC Therapeutics ADCT Q3 2025 earnings

Reported November 10, 2025 · Before market open

Revenue$16.4MMiss by $5.1M
EPS-$0.30Beat by $0.10
Revenue estimate$21.6M
EPS estimate-$0.40

Next report

Nov 10, 2026 (in 2 months)
Revenue estimate$18.4M
EPS estimate-$0.21

FAQ

When did ADC Therapeutics report Q3 2025 earnings?
ADC Therapeutics (ADCT) reported Q3 2025 earnings on November 10, 2025 before market open.
What were ADC Therapeutics's Q3 2025 revenue and EPS?
ADC Therapeutics reported revenue of $16.4M and eps of $-0.30 for Q3 2025.
Did ADC Therapeutics beat estimates in Q3 2025?
Revenue missed the consensus estimate of $21.6M by $5.1M. EPS beat the consensus estimate of $-0.40 by $0.10.
How did ADC Therapeutics's Q3 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue declined 11.0% from $18.5M a year earlier and eps grew 28.6% from $-0.42.
Where can I find ADC Therapeutics's Q3 2025 SEC filings?
You can read the 8-K earnings release (0001628280-25-050796) and the 10-Q periodic report (0001628280-25-051095) directly on SEC EDGAR. The filing index links above go to sec.gov.